Metraipolis › archive › dc_61481e65c8ee

Circulating Tumor DNA (ctDNA) Clearance After Immune Checkpoint Inhibition (ICI) with Radiotherapy (RT) as a Prognostic Biomarker for Advanced Melanoma — Europe PMC PMID:42794998

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42794998
DOI
10.3390/cancers18183032
License (as archived)
solo-consultazione
Archived
2026-10-07T14:37:10.420Z
SHA-256 of the archived text
3f4430bb0759769f8a40c3b00f9ccd4b9e18d6f93eae6b0d1987a91e94dc0ac5
Stable URL of this page
https://metraipolis.com/documento/dc_61481e65c8ee

How to cite

Circulating Tumor DNA (ctDNA) Clearance After Immune Checkpoint Inhibition (ICI) with Radiotherapy (RT) as a Prognostic Biomarker for Advanced Melanoma — Europe PMC PMID:42794998 — Europe PMC (en), https://europepmc.org/article/MED/42794998 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_61481e65c8ee (Metraipolis archive dc_61481e65c8ee, sha256 3f4430bb0759769f8a40c3b00f9ccd4b9e18d6f93eae6b0d1987a91e94dc0ac5)
BibTeX
@misc{dc61481e65c8ee,
  title = {Circulating Tumor DNA (ctDNA) Clearance After Immune Checkpoint Inhibition (ICI) with Radiotherapy (RT) as a Prognostic Biomarker for Advanced Melanoma — Europe PMC PMID:42794998},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42794998},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_61481e65c8ee; sha256 3f4430bb0759769f8a40c3b00f9ccd4b9e18d6f93eae6b0d1987a91e94dc0ac5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794998. Agents can read the archived copy with the MCP tool read_document.